Skip to main content

Design Therapeutics, Inc.

DSGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001807120

No open-market purchases or sales by Design Therapeutics, Inc. insiders were filed in the last 90 days; 136 institutions reported holding it in 13F filings for Q2 2026, worth $626.4M in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in Design Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
136
+12 vs. Q1 2026
Shares held
43.3M
+5.32M (+14.0%) vs. Q1 2026
Total value
$626.4M
+$222.3M (+55.0%) vs. Q1 2026
New holders
28
61 more added
Sold out
16
32 more reduced

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DSGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 136 institutions
Q1 2021: 43 institutionsQ2 2021: 50 institutionsQ3 2021: 52 institutionsQ4 2021: 60 institutionsQ1 2022: 63 institutionsQ2 2022: 74 institutionsQ3 2022: 79 institutionsQ4 2022: 83 institutionsQ1 2023: 96 institutionsQ2 2023: 97 institutionsQ3 2023: 87 institutionsQ4 2023: 88 institutionsQ1 2024: 93 institutionsQ2 2024: 95 institutionsQ3 2024: 100 institutionsQ4 2024: 95 institutionsQ1 2025: 98 institutionsQ2 2025: 93 institutionsQ3 2025: 95 institutionsQ4 2025: 117 institutionsQ1 2026: 125 institutionsQ2 2026: 136 institutions
Value heldQ2 2026: $626.4M
Q1 2021: $755.2MQ2 2021: $546.2MQ3 2021: $414.8MQ4 2021: $773.1MQ1 2022: $613.7MQ2 2022: $541.7MQ3 2022: $667.2MQ4 2022: $414.2MQ1 2023: $223.3MQ2 2023: $244.4MQ3 2023: $77.6MQ4 2023: $84.0MQ1 2024: $123.9MQ2 2024: $107.5MQ3 2024: $172.3MQ4 2024: $206.5MQ1 2025: $133.0MQ2 2025: $116.4MQ3 2025: $259.7MQ4 2025: $357.6MQ1 2026: $404.1MQ2 2026: $626.4M
Institutions holding DSGN and their total value by quarter
QuarterHoldersValue
Q2 2026136$626.4M
Q1 2026125$404.1M
Q4 2025117$357.6M
Q3 202595$259.7M
Q2 202593$116.4M
Q1 202598$133.0M
Q4 202495$206.5M
Q3 2024100$172.3M
Q2 202495$107.5M
Q1 202493$123.9M
Q4 202388$84.0M
Q3 202387$77.6M
Q2 202397$244.4M
Q1 202396$223.3M
Q4 202283$414.2M
Q3 202279$667.2M
Q2 202274$541.7M
Q1 202263$613.7M
Q4 202160$773.1M
Q3 202152$414.8M
Q2 202150$546.2M
Q1 202143$755.2M

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Design Therapeutics, Inc.; share changes are against Q1 2026.

Institutions holding DSGN in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
KVP Capital Advisors, LP185,000$2.68M1.96%+185,000New
Eversept Partners, LP190,000$2.75M0.15%+190,000New
D. E. Shaw & Co., Inc.195,645$2.83M0.00%−274,625−58.4%Reduced
Prudential Financial Inc224,170$3.24M0.00%+178,360+389.3%Added
Vanguard Fiduciary Trust Co230,202$3.33M0.00%+34,544+17.7%Added
Vanguard Portfolio Management LLC251,442$3.64M0.00%+112,877+81.5%Added
Charles Schwab Investment Management Inc271,264$3.93M0.00%+29,779+12.3%Added
Acuta Capital Partners, LLC282,564$4.09M2.85%+136,664+93.7%Added
Algert Global LLC296,085$4.28M0.05%+91,346+44.6%Added
Northern Trust Corp353,197$5.11M0.00%+52,918+17.6%Added
Kennedy Capital Management, Inc.384,036$5.56M0.10%+112,482+41.4%Added
Renaissance Technologies LLC387,913$5.61M0.01%−20,287−5.0%Reduced
Qube Research & Technologies Ltd437,079$6.32M0.01%+402,896+1,178.6%Added
Siren, L.L.C.523,212$7.57M0.15%+523,212New
Acadian Asset Management LLC537,479$7.77M0.01%−79,002−12.8%Reduced
Jacobs Levy Equity Management, Inc565,597$8.18M0.03%+276,212+95.4%Added
Goldman Sachs Group Inc656,584$9.50M0.00%+151,866+30.1%Added
Dimensional Fund Advisors LP694,743$10.1M0.00%+262,903+60.9%Added
Woodline Partners LP700,354$10.1M0.03%−261,147−27.2%Reduced
State Street Corp736,221$10.7M0.00%+76,646+11.6%Added
Morgan Stanley765,425$11.1M0.00%+108,860+16.6%Added
FMR LLC776,462$11.2M0.00%−21,949−2.7%Reduced
Sofinnova Investments, Inc.865,135$12.5M0.67%+865,135New
Geode Capital Management, LLC958,417$13.9M0.00%+265,899+38.4%Added
Almitas Capital LLC1,026,893$14.9M3.56%−503,442−32.9%Reduced
Caption Management, LLC1,118,098$16.2M0.57%+1,031,390+1,189.5%Added
Vanguard Capital Management LLC1,571,022$22.7M0.00%+221,172+16.4%Added
Vivo Capital, LLC1,612,903$23.3M2.13%00.0%Unchanged
Frazier Life Sciences Management, L.P.1,809,854$26.2M0.57%+1,809,854New
Trails Edge Capital Partners, LP2,001,282$29.0M4.60%+1,149,269+134.9%Added
Point72 Asset Management, L.P.2,366,453$34.2M0.05%−356,301−13.1%Reduced
BlackRock, Inc.2,660,024$38.5M0.00%+526,260+24.7%Added
Driehaus Capital Management LLC2,661,115$38.5M0.22%+916,128+52.5%Added
Baker Bros. Advisors LP2,678,430$38.8M0.19%+92,452+3.6%Added
Logos Global Management LP3,000,000$43.4M1.87%+1,050,000+53.8%Added
Sr One Capital Management, LP6,526,476$94.4M9.09%00.0%Unchanged
Ra Capital Management, L.P.0$00.00%−2,972,973−100.0%Sold out
Kynam Capital Management, LP0$00.00%−784,606−100.0%Sold out
Marshall Wace, LLP0$00.00%−151,008−100.0%Sold out
Lynx1 Capital Management LP0$00.00%−119,516−100.0%Sold out
Jane Street Group, LLC0$00.00%−103,902−100.0%Sold out
EAM Investors, LLC0$00.00%−78,949−100.0%Sold out
Velan Capital Investment Management LP0$00.00%−20,000−100.0%Sold out
Engineers Gate Manager LP0$00.00%−16,090−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−15,294−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−14,749−100.0%Sold out
Mariner, LLC0$00.00%−13,066−100.0%Sold out
Baader Bank INC0$00.00%−12,792−100.0%Sold out
Mirabella Financial Services LLP0$00.00%−11,814−100.0%Sold out
ADAR1 Capital Management, LLC0$00.00%−10,000−100.0%Sold out
Root Financial Partners, LLC0$00.00%−38−100.0%Sold out
MAI Capital Management0$00.00%−8−100.0%Sold out
CWM, LLC––––Not filed